Home | Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents
Published clinical_trials Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents has 2 revisions.
RevisionStatus
Saved 07/07/2021 - 9:44am by lazara
current revision (published)
Saved 01/07/2021 - 6:25pm by Gladys
archived
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.